Font Size:
a
A
A
Keyword [Brain iron]
Result: 41 - 60 | Page: 3 of 4
41.
The Protective Effect Of Deferoxamine In The Hypoxic-ischemic White Matter Injury
42.
The Clinical Study On Detection Of Brain Iron Content In Epileptic Patients Through SWI And The Changes Of Serum Iron And Serum Ferritin
43.
The Research Of Parkinson’s Disease Patients’ Regions Of Interest In The Brain Multimodal Magnetic Resonance Imaging
44.
A MR Imaging Study Focusing On Brain Iron And Network Analysis In Parkinson’s Disease
45.
Research On Brain Iron Using Quantitative Susceptibility Mapping With Application To The MPTP Mouse Model Of Parkinson’s Disease
46.
Relationship Between Brain Iron Deposition By Susceptibility Weighted Imaging And Serum Iron Content In Parkinson Disease
47.
The Protective Effect Of Dexmedetomidine On Lipopolysaccharide-induced Neuroinflammation In Aged Mice And Its Relationship With Brain Iron Metabolism
48.
The Research On Brain Iron In Depression Patients Based On Magnetic Susceptibility Mapping
49.
Mutation Analyses Of Neurodegeneration With Brain Iron Accumulation And The Functional Study Of PLA2G6
50.
Quantitative Measurement Of Brain Iron Deposition In Patients With Minimal Hepatic Encephalopathy Using Susceptibility Mapping
51.
The Correlation Between Freezing Of Gait And Brain Iron Deposition In Parkinson’s Disease
52.
Quantitative Measurement Of Brain Iron Deposition,Brain Structure And Function In Children With Beta-TM On MRI
53.
Correlation Between Brain Iron Deposition And Motor Symptoms In Patients With Parkinson’s Disease
54.
Comparative Study Of Brain Iron Metabolism In Multiple Sclerosis And Neuromyelitis Optica Spectrum Disorder Patients By MRI
55.
Quantitative Measurement Of Myelin Sheath And Iron In The Brain Based On MRI
56.
Association Between Cognitive Function And Brain Iron Deposition In Patients Of MCI、AD And VCI
57.
SWI Detection Of Brain Iron Content In WD Patients And Its Relationship With Neurological Function And TCM Syndrome
58.
Quantification of localized brain iron sources using magnetic resonance phase
59.
Brain iron deficiency in humans and animal models
60.
Therapeutic implications of mutant huntingtin-induced dysregulation of brain iron homeostasis in a mouse model of Huntington's disease
<<First
<Prev
Next>
Last>>
Jump to